Nav: Home

Current Hiv News and Events

Current Hiv News and Events, Hiv News Articles.
Sort By: Most Relevant | Most Viewed
Page 1 of 25 | 1000 Results
USC analysis solves puzzle of poor cancer prognosis in young Americans
For decades, some researchers believed cancer survival rates were dismally low among adolescents and young adults in the United States. (2018-10-15)
HIV-positive infants are at high risk for acquiring congenital cytomegalovirus infection
Infants born to HIV-positive mothers had high rates of congenital cytomegalovirus, or CMV. (2018-10-15)
CDC researchers examine HIV-related stigma among US healthcare providers
A Systemic Review from the US Centers for Disease Control and Prevention analyzed studies of HIV-related stigma among healthcare provider and identified three main themes: attitudes, beliefs, and behaviors; quality of patient care; and education and training. (2018-10-09)
Retention in HIV care drops after release from incarceration
Fewer than half of people with HIV are retained in care three years after release from incarceration, according to a study in the US published Oct. (2018-10-09)
Long-acting injectable implant shows promise for HIV treatment and prevention
A long-acting antiretroviral drug formulation, developed by UNC School of Medicine researchers, shows promise for HIV treatment and prevention in a study published in Nature Communications. (2018-10-08)
NUS researchers uncover new role of TIP60 protein in controlling tumor formation
Scientists from the Cancer Science Institute of Singapore have discovered a new molecular pathway that controls colorectal cancer development, and their exciting findings open new therapeutic opportunities. (2018-10-07)
Study links individual HPV types to HIV infection
An international research team led by a UC Riverside scientist has for the first time identified individual types of the human papillomavirus, or HPV, that are specifically linked to HIV infection. (2018-10-05)
New details of HIV life cycle
The discovery of a small molecule that plays an important part of the HIV life cycle may lead to the development of new treatments for the virus. (2018-10-05)
Study finds standard treatment for common STD doesn't eliminate parasite in some women
A new study led by an infectious disease epidemiologist at Tulane University School of Public Health and Tropical Medicine could change the way doctors treat a common sexually transmitted disease. (2018-10-05)
Would you rather die of liver failure or live with HIV?
In 2017, doctors from the Transplant Unit at the Wits Donald Gordon Medical Centre performed what is believed to be the world's first intentional liver transplant from a mother living with HIV to her critically ill HIV negative child, who had end-stage liver disease. (2018-10-04)
Efavirenz in HIV-positive pregnant women, risk of neurological condition in children
Antiretroviral therapy (ART) is a vital treatment that helps prevent a pregnant woman from passing HIV to her baby, but one type of ART medication may increase the risk the child will develop a neurological condition, according to new research being presented at IDWeek 2018. (2018-10-04)
Combination therapy targets latent reservoir of HIV
In a new study, Dan H. Barouch, MD, PhD, Director of the Center for Virology and Vaccine Research at Beth Israel Deaconess Medical Center, and colleagues demonstrate that administering broadly neutralizing antibodies (bNAb) designed to target HIV in combination with agents that stimulate the innate immune system delayed viral rebound following discontinuation of ART in monkeys. (2018-10-03)
Anti-integrin therapy effect on intestinal immune system in HIV-infected patients
In a study published today in Science Translational Medicine, Mount Sinai researchers describe for the first time a mechanism that may shrink collections of immune cells in the gastrointestinal (GI) tract, called lymphoid aggregates, where HIV may lay sequestered. (2018-10-03)
Inflammatory bowel disease drug attacks safe haven for HIV
A first in human study of patients with both inflammatory bowel disease (IBD) and HIV found that administering a drug for IBD disrupts congregating T cells infected with HIV in the gut -- which form a persistent reservoir of infection. (2018-10-03)
No 'reservoir': detectable HIV-1 in treated human liver cells found to be inert
In a proof-of-principle study, researchers at Johns Hopkins report that a certain liver immune cell called a macrophage contains only defective or inert HIV-1 copies, and aren't likely to restart infection on their own in HIV-1-infected people on long-term antiretroviral therapy (ART). (2018-10-01)
Combination antibody therapy results in long-term viral suppression in HIV infection
A new generation of broadly neutralizing antibodies provides a novel approach to treating HIV infection. (2018-09-27)
Researchers find how Natural Killer cells regulate protective HIV antibodies
In the quest to develop a vaccine that triggers the immune system to prevent HIV infection, researchers have focused on identifying and eliciting a particular type of antibody that is capable of neutralizing the virus. (2018-09-27)
Unusual case of father-to-son HIV transmission reported
Diagnosis of HIV-1 infection in the 4-year old child of an HIV-negative mother led to a forensic analysis to determine the source of the infection and try to date the transmission of the virus. (2018-09-27)
Combination HIV antibody infusions safely maintain viral suppression in select individuals
A small group of people living with HIV sensitive to two potent anti-HIV broadly neutralizing antibodies (bNAbs) -- 3BNC117 and 10-1074 -- tolerated multiple infusions of the antibodies and suppressed HIV for more than 15 weeks after stopping antiretroviral therapy (ART). (2018-09-26)
In clinical trials, new antibody therapy controls HIV for months after treatment
A new clinical trial shows that broadly neutralizing antibodies can suppress HIV for up to four months, far longer than currently available drugs. (2018-09-26)
Proof-of-concept HIV immunotherapy study passes Phase 1 safety trial
Preliminary results from a phase I clinical trial have demonstrated the safety and tolerability of a cell therapy involving the ex vivo expansion of T cells and their subsequent infusion into HIV-infected individuals previously treated with antiretroviral therapy (ART). (2018-09-21)
Affordable Care Act: Study finds surprising gaps in HIV care providers' knowledge
More than a quarter of providers were unable to say whether their state had expanded Medicaid, the national survey found. (2018-09-20)
Festschrift dedicated to Mathilde Krim includes scientific research by Krim fellows
A special Festschrift dedicated to the memory of Dr. Mathilde Krim celebrates her life and medical and scientific career, including her leadership role as the Founder of the American Foundation of AIDS Research (amfAR). (2018-09-20)
FRESH program combines basic science with social benefits for women at risk of HIV
A program established by the Ragon Institute of MGH, MIT and Harvard is addressing the persistently elevated risk of HIV infection among young women in South Africa from two angles -- first, investigating biological factors that modulate infection risk and the early immunologic events following viral exposure, and second, alleviating the socioeconomic factors that limit opportunities for young women, the group at greatest risk in the region hit hardest by the HIV epidemic. (2018-09-14)
Largest study of 'post-treatment controllers' reveals clues about HIV remission
Most HIV patients need to take daily anti-retroviral therapy -- if they suspend treatment, HIV will rebound within 3-4 weeks. (2018-09-13)
New study finds HIV outbreak in Indiana could have been prevented
An HIV outbreak among people who inject drugs in Indiana from 2011 to 2015 could have been avoided if the state's top health and elected officials had acted sooner on warnings, a new study by the Yale School of Public Health finds. (2018-09-13)
Special antibodies could lead to HIV vaccine
Around one percent of people infected with HIV produce antibodies that block most strains of the virus. (2018-09-10)
Immunotherapy may be efficacious in patients with HIV-associated Kaposi's sarcoma
Among a small cohort of patients with HIV-associated Kaposi's sarcoma treated with immune checkpoint inhibitors, more than 65 percent had partial or complete remission. (2018-09-07)
Researchers date 'hibernating' HIV strains, advancing BC's leadership in HIV cure research
Researchers have developed a novel way for dating 'hibernating' HIV strains, in an advancement for HIV cure research. (2018-09-05)
DNA technology provides novel strategy for delivery of complex anti-HIV agent
Scientists at The Wistar Institute have applied their synthetic DNA technology to engineer a novel eCD4-Ig anti-HIV agent and to enhance its potency in vivo, providing a new simple strategy for constructing complex therapeutics for infectious agents as well as for diverse implications in therapeutic delivery. (2018-09-04)
New program boosts use of HIV medications in injection-drug users
A relatively simple effort to provide counseling and connect injection-drug users with resources could prove powerful against the spread of HIV in a notoriously hard-to-reach population, new research suggests. (2018-08-30)
Novel intervention halves rate of death among people living with HIV who inject drugs
An intervention designed to facilitate treatment for HIV and substance use was associated with a 50 percent reduction in mortality for people living with HIV who inject illicit drugs, a study has found. (2018-08-30)
HPTN 074 demonstrates significant benefits among people living with HIV who inject drugs
Investigators from the HIV Prevention Trials Network (HPTN) today announced The Lancet has published key results from HPTN 074. (2018-08-30)
HIV/AIDS research yields dividends across medical fields
Since the first cases of AIDS were reported in the United States 37 years ago, the National Institutes of Health has invested more than $69 billion in the understanding, treatment and prevention of HIV/AIDS. (2018-08-28)
Crowdsourced multimedia campaign to boost HIV testing in China
A crowdsourced intervention led to an increase in the number of gay men who got tested for HIV in eight cities in China, researchers led by Joseph Tucker from the University of North Carolina Chapel Hill, USA, report this week in PLOS Medicine. (2018-08-28)
Crowdsourcing campaigns increase HIV testing among at-risk men in China
Researchers at the University of North Carolina at Chapel Hill have found that crowdsourced campaigns can motivated men at-risk of HIV infection in China to get tested. (2018-08-28)
HIV RNA expression inhibitors may restore immune function in HIV-infected individuals
Immune activation and inflammation persist in the majority of treated HIV-infected individuals and is associated with excess risk of mortality and morbidity. (2018-08-27)
Study shows children with multidrug-resistant tuberculosis can be treated
The results of a large, international systematic review published in the journal PLOS Medicine show that tuberculosis treatment is successful in children with multidrug-resistant tuberculosis (MDR-TB). (2018-08-21)
Untreated genital warts may increase risk of HIV transmission
A new study has shown that genital warts may promote HIV sexual transmission and, in turn, their treatment and prevention could help decrease the spread of the disease. (2018-08-21)
Education program successful at reducing forced sex in South African adolescents
A 12-hour theory-based, culturally adapted educational program presented in sixth-grade classrooms in South Africa significantly reduced the chances that the students would force sex on someone else, an effect that held true over the four years the students were followed. (2018-08-21)
Page 1 of 25 | 1000 Results
   First   Previous   Next      Last   

Best Science Podcasts 2018

We have hand picked the best science podcasts for 2018. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Hacking The Law
We have a vision of justice as blind, impartial, and fair — but in reality, the law often fails those who need it most. This hour, TED speakers explore radical ways to change the legal system. Guests include lawyer and social justice advocate Robin Steinberg, animal rights lawyer Steven Wise, political activist Brett Hennig, and lawyer and social entrepreneur Vivek Maru.
Now Playing: Science for the People

#495 Earth Science in Space
Some worlds are made of sand. Some are made of water. Some are even made of salt. In science fiction and fantasy, planet can be made of whatever you want. But what does that mean for how the planets themselves work? When in doubt, throw an asteroid at it. This is a live show recorded at the 2018 Dragon Con in Atlanta Georgia. Featuring Travor Valle, Mika McKinnon, David Moscato, Scott Harris, and moderated by our own Bethany Brookshire. Note: The sound isn't as good as we'd hoped but we love the guests and the conversation and we wanted to...